rs1800407

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM5BP4_StrongBP6_Very_StrongBA1

The NM_000275.3(OCA2):​c.1256G>A​(p.Arg419Gln) variant causes a missense change. The variant allele was found at a frequency of 0.068 in 1,613,592 control chromosomes in the GnomAD database, including 4,410 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R419W) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.049 ( 241 hom., cov: 32)
Exomes 𝑓: 0.070 ( 4169 hom. )

Consequence

OCA2
NM_000275.3 missense

Scores

2
8
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 7.14

Publications

154 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000275.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr15-27985173-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194160.
BP4
Computational evidence support a benign effect (MetaRNN=0.0110088885).
BP6
Variant 15-27985172-C-T is Benign according to our data. Variant chr15-27985172-C-T is described in ClinVar as Benign. ClinVar VariationId is 963.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0693 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000275.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
NM_000275.3
MANE Select
c.1256G>Ap.Arg419Gln
missense
Exon 13 of 24NP_000266.2Q04671-1
OCA2
NM_001300984.2
c.1184G>Ap.Arg395Gln
missense
Exon 12 of 23NP_001287913.1Q04671-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
ENST00000354638.8
TSL:1 MANE Select
c.1256G>Ap.Arg419Gln
missense
Exon 13 of 24ENSP00000346659.3Q04671-1
OCA2
ENST00000353809.9
TSL:1
c.1184G>Ap.Arg395Gln
missense
Exon 12 of 23ENSP00000261276.8Q04671-2
OCA2
ENST00000910120.1
c.1256G>Ap.Arg419Gln
missense
Exon 13 of 26ENSP00000580179.1

Frequencies

GnomAD3 genomes
AF:
0.0486
AC:
7402
AN:
152172
Hom.:
241
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0141
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0671
Gnomad ASJ
AF:
0.0493
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0313
Gnomad FIN
AF:
0.0429
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0709
Gnomad OTH
AF:
0.0512
GnomAD2 exomes
AF:
0.0469
AC:
11577
AN:
246792
AF XY:
0.0485
show subpopulations
Gnomad AFR exome
AF:
0.0114
Gnomad AMR exome
AF:
0.0436
Gnomad ASJ exome
AF:
0.0492
Gnomad EAS exome
AF:
0.000327
Gnomad FIN exome
AF:
0.0441
Gnomad NFE exome
AF:
0.0648
Gnomad OTH exome
AF:
0.0559
GnomAD4 exome
AF:
0.0700
AC:
102342
AN:
1461302
Hom.:
4169
Cov.:
35
AF XY:
0.0689
AC XY:
50090
AN XY:
726900
show subpopulations
African (AFR)
AF:
0.0110
AC:
369
AN:
33476
American (AMR)
AF:
0.0457
AC:
2043
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0496
AC:
1296
AN:
26128
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39698
South Asian (SAS)
AF:
0.0313
AC:
2698
AN:
86232
European-Finnish (FIN)
AF:
0.0434
AC:
2303
AN:
53094
Middle Eastern (MID)
AF:
0.0336
AC:
194
AN:
5768
European-Non Finnish (NFE)
AF:
0.0803
AC:
89250
AN:
1111814
Other (OTH)
AF:
0.0691
AC:
4173
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
5590
11179
16769
22358
27948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3344
6688
10032
13376
16720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0486
AC:
7403
AN:
152290
Hom.:
241
Cov.:
32
AF XY:
0.0474
AC XY:
3528
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0141
AC:
585
AN:
41576
American (AMR)
AF:
0.0670
AC:
1025
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0493
AC:
171
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5180
South Asian (SAS)
AF:
0.0315
AC:
152
AN:
4826
European-Finnish (FIN)
AF:
0.0429
AC:
455
AN:
10602
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0710
AC:
4827
AN:
68018
Other (OTH)
AF:
0.0502
AC:
106
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
340
679
1019
1358
1698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0623
Hom.:
1147
Bravo
AF:
0.0480
Asia WGS
AF:
0.0140
AC:
48
AN:
3478
EpiCase
AF:
0.0730
EpiControl
AF:
0.0708

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Tyrosinase-positive oculocutaneous albinism (1)
-
-
-
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.57
D
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.99
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.41
T
MutationAssessor
Benign
1.5
L
PhyloP100
7.1
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.5
N
REVEL
Uncertain
0.57
Sift
Benign
0.094
T
Sift4G
Benign
0.11
T
Varity_R
0.21
gMVP
0.82
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1800407;
hg19: chr15-28230318;
COSMIC: COSV62342487;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.